-
Stanford Medicine study discovers what’s behind heart cell damage from chemotherapy
Researchers used a new screening technique to identify genes involved in heart cell damage during a common chemotherapy treatment. They also found a drug that may be able to prevent it.
-
FDA approves Stanford Medicine-developed drug that treats rare heart disease
New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.
News & Research
-
Jay Bhattacharya, MD, PhD nominated as director of National Institutes of Health
Stanford Medicine congratulates Stanford professor Jay Bhattacharya, MD, PhD, on his nomination to lead the National Institutes of Health.
-
Brain malformations linked to protein misfolding
Mutations in a complex that helps proteins fold correctly are tied to developmental disorders that include seizures and intellectual disability, Stanford Medicine-led research has found.
-
AI tool reads biopsy images
Researchers used artificial intelligence to predict the activity of thousands of genes in tumors based on routinely collected images of tumor biopsies. It could guide treatment without costly genomic tests.
-
Stanford CME online program addition
Stanford Medicine launches a pilot program collaboration to expand its CME courses to a broader audience worldwide, setting a new standard for online medical education.
-
CAR-T cells fight brain, spinal tumors
CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a Stanford Medicine trial found.
-
Antibody composition shapes flu severity
Why do some people develop severe flu symptoms? A Stanford Medicine study points the finger at an unsung portion of the antibodies our immune systems generate to fend off invading pathogens.
-
ecDNA catapults into spotlight
Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings and potential therapies.
-
Digital health forum stresses equity
Artificial intelligence and digital technology experts convened to discuss the benefits, challenges and potential of a digitally driven future in biomedical research and health care.
-
Colon cancer screening options
Blood tests for colorectal cancer are an option for patients who would otherwise not be screened, but they are not as effective as colonoscopies or stool tests, a Stanford Medicine-led study found.
-
$70 million NIH grant
The goal of the Clinical and Translational Science Award is to convert new treatments into care more rapidly.
Other Stanford
Medicine News
- December 5, 2024 – Pasca Lab
Newly discovered sets of chemicals coax tiny brain organoids to grow rare types of neurons
Stanford Medicine researchers were able identify critical combinations of signaling molecules and timing windows during development in which diverse cell types and brain regions are formed.
- October 25, 2024 – Stanford Report
Innovative techniques shed light on hamstring injury in athletes
Two new studies yield insights into hamstring injury and prevention under real-world conditions, enhancing our understanding of how muscles adapt to training.
- October 21, 2024 – Stanford Report
How to pick – and solve – the next great problem
Bioengineering Professor Michael Fischbach shares his framework for choosing impactful problems to work on and finding optimal solutions.